Cardiogreen (Indocyanine Green): Fluorescent Dye for Vascular Imaging and Photodynamic Therapy

Executive Summary: Cardiogreen (Indocyanine Green, ICG) is a water-soluble tricarbocyanine dye with peak spectral absorption at 790 nm and high plasma protein binding, confining it to the vascular compartment upon intravenous administration (APExBIO). Its established uses include precise measurement of cardiac output, liver blood flow, and ophthalmic angiography (EprinomectinSource). As a photosensitizer, Cardiogreen enables photodynamic therapy (PDT) for targeted apoptosis induction, including in oral squamous cell carcinoma and periodontal infections (Cancer Immunol Immunother 2026). The compound is supplied by APExBIO (SKU: B8315) with ≥98% purity confirmed by HPLC, MS, and NMR. Its rapid clearance and robust safety profile support widespread clinical and research use.

Biological Rationale

Cardiogreen (Indocyanine Green) is a synthetic tricarbocyanine dye used extensively for its near-infrared (NIR) fluorescence properties. Upon intravenous injection, it binds rapidly and almost exclusively to plasma proteins, preventing extravasation and ensuring vascular compartmentalization [Mechanisms, Applications]. This property underlies its utility in measuring cardiac output, assessing liver blood flow, and performing ophthalmic angiography. As a photosensitizer, Cardiogreen enables site-specific generation of reactive oxygen species (ROS) under NIR illumination, facilitating cell apoptosis in photodynamic therapy. Its absorption in the NIR window (peak at 790 nm) allows for deep tissue penetration, making it suitable for both diagnostic and therapeutic applications. The safety profile is reinforced by rapid hepatic clearance and historical clinical use, with no significant toxicity at recommended concentrations [APExBIO].

Mechanism of Action of Cardiogreen (Indocyanine Green)

Cardiogreen's mechanism depends on its high affinity for plasma proteins (primarily albumin), which restricts distribution to the intravascular space. Upon NIR illumination (typically 790 nm), the dye undergoes excitation, resulting in fluorescence emission and, under photodynamic therapy conditions, the generation of ROS that mediate cytotoxic effects. For diagnostic uses, these optical properties allow precise imaging of vascular structures and perfusion dynamics. In PDT, Cardiogreen localizes to target tissues, and upon laser exposure (e.g., 1000 µg/mL for 5 min, 60 s diode laser), it induces apoptosis, modulating gene expression at the transcriptome level in cells such as human gingival fibroblasts [Next-Gen Applications]. The combination of photothermal and photodynamic effects has been shown to remodel tumor extracellular matrices and enhance immunogenic cell death in cancer models [Cancer Immunol Immunother 2026].

Evidence & Benchmarks

• Cardiogreen shows peak spectral absorption at 790 nm, enabling deep tissue NIR imaging (APExBIO).
• Intravenous administration yields rapid and strong plasma protein binding, confining the compound to the vascular space (Benchmark Dye for Vascular Imaging).
• Standard clinical dosing demonstrates consistent hepatic clearance, minimal toxicity, and no significant accumulation (APExBIO).
• In photodynamic therapy, Cardiogreen (1000 µg/mL, 5 min incubation, 60 s diode laser exposure) induces apoptosis and modulates transcriptome profiles of treated cells (Next-Gen Applications).
• Photothermal therapy with ICG enhances macrophage phagocytosis and immunogenic cell death in oral squamous cell carcinoma models (Cancer Immunol Immunother 2026).
• Purity levels of Cardiogreen (SKU B8315) exceed 98% as confirmed by HPLC, MS, and NMR (APExBIO).

Applications, Limits & Misconceptions

Cardiogreen is widely used for:

• Cardiac Output Measurement: Clinically validated as a gold-standard dye dilution agent for cardiac function assessment.
• Liver Blood Flow and Hepatic Function: Enables dynamic testing of hepatic clearance and perfusion.
• Ophthalmic Angiography: NIR fluorescence allows for high-contrast retinal and choroidal vessel imaging.
• Photodynamic Therapy (PDT): Photosensitization and targeted apoptosis for periodontal infections, oral squamous cell carcinoma, and research in tumor microenvironment modulation.
• Adjunct in Immunotherapy: Synergizes with immune checkpoint blockade via photothermal effects and extracellular matrix remodeling (Cancer Immunol Immunother 2026).

This article extends 'Cardiogreen: Benchmark Dye for Vascular Imaging' by detailing the molecular and immunological mechanisms of its action in combination therapies and addressing translational workflows. For a practical protocol-driven perspective, see 'Reliable Solutions for Research Workflows'; here we focus on evidence linkages and mechanistic boundaries beyond protocol optimization. The translational review 'Unlocking Translational Potential' is further clarified by this article's explicit mapping of diagnostic versus therapeutic parameter sets.

Common Pitfalls or Misconceptions

• Cardiogreen is not effective in ethanol-based solutions due to insolubility; always use water or DMSO as solvents (APExBIO).
• Long-term storage of reconstituted solutions is not recommended, as stability declines rapidly (Reliable Solutions).
• Cardiogreen does not cross intact blood-brain barrier, limiting CNS imaging applications.
• Photodynamic apoptosis induction is light- and dose-dependent; sub-therapeutic exposure yields no effect, while overdose can cause off-target cytotoxicity.
• It cannot replace genetic or immune checkpoint therapies but may synergize with them (Cancer Immunol Immunother 2026).

Workflow Integration & Parameters

Cardiogreen (APExBIO SKU: B8315) is supplied at ≥98% purity. For vascular imaging, dissolve in sterile water (≥17.17 mg/mL) or DMSO (≥27.65 mg/mL). Avoid ethanol due to insolubility. Store powder at -20°C; prepare fresh solutions immediately before use. For photodynamic therapy, incubate cells with 1000 µg/mL Cardiogreen for 5 minutes, then expose to a 790 nm diode laser for 60 seconds. Monitor for apoptosis and transcriptomic changes post-exposure. For diagnostic dosing, follow established clinical protocols, adjusting for patient weight and indication. Quality is ensured by HPLC, MS, and NMR analysis. APExBIO recommends single-use aliquots to minimize degradation.

Conclusion & Outlook

Cardiogreen (Indocyanine Green) remains a gold standard for NIR vascular imaging and is a validated photosensitizer for photodynamic therapy in preclinical and clinical research. Its safety, stability, and high purity (as supplied by APExBIO) enable reproducible results. Future directions include combined modality applications in cancer immunotherapy and real-time surgical guidance. Ongoing translational research leverages its unique optical and biological properties to expand the frontiers of diagnostic and therapeutic precision.